Christian Bacilieri, Breganzona (CH); and Gionata Frasca, Minusio (CH)
Assigned to Helsinn Healthcare SA, Pazzallo (CH)
Filed by Helsinn Healthcare SA, Pazallo-Lugano (CH)
Filed on Feb. 25, 2021, as Appl. No. 17/185,206.
Application 17/185,206 is a continuation of application No. 16/863,038, filed on Apr. 30, 2020, granted, now 10,961,195.
Application 16/863,038 is a continuation of application No. 16/259,913, filed on Jan. 28, 2019, granted, now 10,676,440, issued on Jun. 9, 2020.
Application 16/259,913 is a continuation of application No. 15/918,868, filed on Mar. 12, 2018, granted, now 10,233,154, issued on Mar. 19, 2019.
Application 15/918,868 is a continuation of application No. 14/865,370, filed on Sep. 25, 2015, granted, now 9,951,016, issued on Apr. 24, 2018.
Claims priority of provisional application 62/055,836, filed on Sep. 26, 2014.
Prior Publication US 2021/0269401 A1, Sep. 2, 2021
Int. Cl. C07D 213/75 (2006.01)
CPC C07D 213/75 (2013.01)
6 Claims
1. Amorphous 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide having an XRPD pattern substantially as depicted in FIG. 11.